Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
Public ClinicalTrials.gov record NCT02141854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study was to evaluate the efficacy of fluticasone propionate (Fp) multidose dry powder inhaler (MDPI) and fluticasone propionate/salmeterol xinafoate (FS) MDPI when administered over 12 weeks in patients 12 years of age and older with persistent asthma.
Study identification
- NCT ID
- NCT02141854
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 882 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- Sep 2015 (Actual)
- Completion
- Sep 2015 (Actual)
- Last update posted
- Nov 9, 2021
2014 – 2015
United States locations
- U.S. sites
- 85
- U.S. states
- 33
- U.S. cities
- 77
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12429 | Birmingham | Alabama | — | — |
| Teva Investigational Site 12599 | Little Rock | Alaska | — | — |
| Teva Investigational Site 12609 | Phoenix | Arizona | — | — |
| Teva Investigational Site 12445 | Costa Mesa | California | — | — |
| Teva Investigational Site 12454 | Encinitas | California | — | — |
| Teva Investigational Site 12456 | Fresno | California | — | — |
| Teva Investigational Site 12461 | Fullerton | California | — | — |
| Teva Investigational Site 12410 | Huntington Beach | California | — | — |
| Teva Investigational Site 12452 | Huntington Beach | California | — | — |
| Teva Investigational Site 12417 | Long Beach | California | — | — |
| Teva Investigational Site 13017 | Mission Viejo | California | — | — |
| Teva Investigational Site 12462 | Rancho Mirage | California | — | — |
| Teva Investigational Site 12411 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 13018 | San Diego | California | — | — |
| Teva Investigational Site 12413 | San Jose | California | — | — |
| Teva Investigational Site 12403 | Stockton | California | — | — |
| Teva Investigational Site 12444 | Upland | California | — | — |
| Teva Investigational Site 12999 | Vista | California | — | — |
| Teva Investigational Site 12405 | Centennial | Colorado | — | — |
| Teva Investigational Site 12419 | Centennial | Colorado | — | — |
| Teva Investigational Site 13000 | Colorado Springs | Colorado | — | — |
| Teva Investigational Site 12459 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 13004 | Largo | Florida | — | — |
| Teva Investigational Site 12414 | Miami | Florida | — | — |
| Teva Investigational Site 12437 | Miami | Florida | — | — |
| Teva Investigational Site 12427 | Orlando | Florida | — | — |
| Teva Investigational Site 12423 | Ormond Beach | Florida | — | — |
| Teva Investigational Site 12604 | Panama City | Florida | — | — |
| Teva Investigational Site 13316 | Tamarac | Florida | — | — |
| Teva Investigational Site 12606 | Winter Park | Florida | — | — |
| Teva Investigational Site 12435 | Savannah | Georgia | — | — |
| Teva Investigational Site 13315 | Eagle | Idaho | — | — |
| Teva Investigational Site 12439 | River Forest | Illinois | — | — |
| Teva Investigational Site 12449 | Shiloh | Illinois | — | — |
| Teva Investigational Site 12457 | South Bend | Indiana | — | — |
| Teva Investigational Site 12446 | Bangor | Maine | — | — |
| Teva Investigational Site 12602 | Columbia | Maryland | — | — |
| Teva Investigational Site 12432 | Fall River | Massachusetts | — | — |
| Teva Investigational Site 12441 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 12466 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 13001 | Royal Oak | Michigan | — | — |
| Teva Investigational Site 12428 | Ypsilanti | Michigan | — | — |
| Teva Investigational Site 13020 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 12451 | Columbia | Missouri | — | — |
| Teva Investigational Site 12421 | Rolla | Missouri | — | — |
| Teva Investigational Site 12412 | St Louis | Missouri | — | — |
| Teva Investigational Site 12453 | St Louis | Missouri | — | — |
| Teva Investigational Site 12610 | Missoula | Montana | — | — |
| Teva Investigational Site 13021 | Las Vegas | Nevada | — | — |
| Teva Investigational Site 12409 | Skillman | New Jersey | — | — |
| Teva Investigational Site 12464 | Brooklyn | New York | — | — |
| Teva Investigational Site 12603 | The Bronx | New York | — | — |
| Teva Investigational Site 12430 | Charlotte | North Carolina | — | — |
| Teva Investigational Site 12407 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 12415 | Canton | Ohio | — | — |
| Teva Investigational Site 12455 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12463 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12460 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 12426 | Edmond | Oklahoma | — | — |
| Teva Investigational Site 13008 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12406 | Medford | Oregon | — | — |
| Teva Investigational Site 12442 | Portland | Oregon | — | — |
| Teva Investigational Site 12563 | Normal Square | Pennsylvania | — | — |
| Teva Investigational Site 12443 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 12438 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 12408 | Charleston | South Carolina | — | — |
| Teva Investigational Site 12431 | Greenville | South Carolina | — | — |
| Teva Investigational Site 12465 | Mt. Pleasant | South Carolina | — | — |
| Teva Investigational Site 12467 | Mt. Pleasant | South Carolina | — | — |
| Teva Investigational Site 12420 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 12433 | Rock Hill | South Carolina | — | — |
| Teva Investigational Site 13003 | Knoxville | Tennessee | — | — |
| Teva Investigational Site 12425 | Arlington | Texas | — | — |
| Teva Investigational Site 12416 | Dallas | Texas | — | — |
| Teva Investigational Site 12418 | Dallas | Texas | — | — |
| Teva Investigational Site 12440 | El Paso | Texas | — | — |
| Teva Investigational Site 12447 | Killeen | Texas | — | — |
| Teva Investigational Site 13318 | San Antonio | Texas | — | — |
| Teva Investigational Site 13002 | Sugar Land | Texas | — | — |
| Teva Investigational Site 12424 | Waco | Texas | — | — |
| Teva Investigational Site 12422 | South Burlington | Vermont | — | — |
| Teva Investigational Site 12605 | Richmond | Virginia | — | — |
| Teva Investigational Site 12436 | Spokane | Washington | — | — |
| Teva Investigational Site 12564 | Tacoma | Washington | — | — |
| Teva Investigational Site 12448 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02141854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02141854 live on ClinicalTrials.gov.